Search results

AbbVie’s ABBV neuroscience franchise continued to deliver strong growth in the first half of 2026, with sales reaching $6.1 billion, up 21.8% year over year on an operational basis. While the

Prudent pricing, increasing climate-related risks and rapid digital transformation are likely to influence the insurance industry’s outlook in 2026. Although insurers remain exposed to catastrophe

Sprouts Farmers Market, Inc. SFM delivered a mixed second quarter as new-store productivity supported sales growth while comparable-store sales remained soft. Earnings per share came in above the

American States Water Company AWR continues to reward shareholders through regular dividend payments and consistent annual dividend increases. Its long-standing dividend record reflects the strength

Bristol Myers Squibb BMY recently announced that the FDA has granted accelerated approval to iberdomide in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd).

The regimen

Solana Company (HSDT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $79.73 per share a year ago. These figures

Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.55 per share a year ago. These

Cerenome (CNSY) came out with a quarterly loss of $1.31 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to a loss of $0.25 per share a year ago. These figures are